End-of-day quote
Taipei Exchange
23:00:00 28/04/2024 BST
|
5-day change
|
1st Jan Change
|
13.2
TWD
|
+1.54%
|
|
+3.53%
|
+9.54%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
9,791
|
9,096
|
9,580
|
16,650
|
16,153
|
15,123
|
Enterprise Value (EV)
1 |
-1,543
|
-13,570
|
-6,243
|
4,189
|
2,037
|
3,873
|
P/E ratio
|
15.3
x
|
4.52
x
|
2.97
x
|
2.59
x
|
2.67
x
|
6.85
x
|
Yield
|
-
|
-
|
-
|
7.46%
|
-
|
-
|
Capitalization / Revenue
|
0.14
x
|
0.09
x
|
0.09
x
|
0.16
x
|
0.31
x
|
0.21
x
|
EV / Revenue
|
-0.02
x
|
-0.13
x
|
-0.06
x
|
0.04
x
|
0.04
x
|
0.05
x
|
EV / EBITDA
|
0.34
x
|
-1.41
x
|
-0.36
x
|
0.22
x
|
-0.1
x
|
4.46
x
|
EV / FCF
|
-0.35
x
|
0.29
x
|
0.19
x
|
0.56
x
|
0.16
x
|
-0.52
x
|
FCF Yield
|
-289%
|
346%
|
513%
|
178%
|
636%
|
-192%
|
Price to Book
|
0.64
x
|
0.37
x
|
0.26
x
|
0.41
x
|
0.54
x
|
0.39
x
|
Nbr of stocks (in thousands)
|
1,255,000
|
1,255,000
|
1,255,000
|
1,255,000
|
1,255,000
|
1,255,000
|
Reference price
2 |
7.802
|
7.248
|
7.634
|
13.27
|
12.87
|
12.05
|
Announcement Date
|
29/03/19
|
31/03/20
|
31/03/21
|
30/03/22
|
16/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
69,041
|
103,474
|
108,218
|
102,694
|
52,098
|
71,554
|
EBITDA
1 |
-4,584
|
9,606
|
17,202
|
18,662
|
-20,665
|
868.8
|
EBIT
1 |
-4,974
|
9,241
|
16,832
|
18,266
|
-21,063
|
476.2
|
Operating Margin
|
-7.2%
|
8.93%
|
15.55%
|
17.79%
|
-40.43%
|
0.67%
|
Earnings before Tax (EBT)
1 |
1,311
|
2,898
|
3,931
|
8,286
|
6,657
|
2,207
|
Net income
1 |
641.6
|
2,016
|
3,237
|
6,465
|
6,067
|
2,206
|
Net margin
|
0.93%
|
1.95%
|
2.99%
|
6.3%
|
11.65%
|
3.08%
|
EPS
2 |
0.5112
|
1.604
|
2.574
|
5.129
|
4.812
|
1.758
|
Free Cash Flow
1 |
4,464
|
-46,941
|
-32,055
|
7,466
|
12,945
|
-7,440
|
FCF margin
|
6.47%
|
-45.37%
|
-29.62%
|
7.27%
|
24.85%
|
-10.4%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
40.01%
|
-
|
-
|
FCF Conversion (Net income)
|
695.77%
|
-
|
-
|
115.49%
|
213.38%
|
-
|
Dividend per Share
|
-
|
-
|
-
|
0.9901
|
-
|
-
|
Announcement Date
|
29/03/19
|
31/03/20
|
31/03/21
|
30/03/22
|
16/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
11,334
|
22,665
|
15,823
|
12,461
|
14,117
|
11,249
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
4,464
|
-46,941
|
-32,055
|
7,466
|
12,945
|
-7,440
|
ROE (net income / shareholders' equity)
|
3.83%
|
10.1%
|
10.6%
|
16.6%
|
17%
|
6.43%
|
ROA (Net income/ Total Assets)
|
-0.74%
|
1.22%
|
1.92%
|
1.87%
|
-2.02%
|
0.04%
|
Assets
1 |
-86,395
|
165,630
|
168,935
|
346,010
|
-300,802
|
5,083,694
|
Book Value Per Share
2 |
12.10
|
19.60
|
29.30
|
32.70
|
24.00
|
30.60
|
Cash Flow per Share
2 |
9.030
|
18.20
|
12.90
|
10.10
|
11.40
|
9.160
|
Capex
1 |
294
|
501
|
144
|
98.2
|
82.9
|
42.3
|
Capex / Sales
|
0.43%
|
0.48%
|
0.13%
|
0.1%
|
0.16%
|
0.06%
|
Announcement Date
|
29/03/19
|
31/03/20
|
31/03/21
|
30/03/22
|
16/03/23
|
14/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +9.54% | 508M | | +10.48% | 80.6B | | +8.42% | 51.13B | | +2.47% | 48.65B | | +10.21% | 42.58B | | +7.93% | 40.23B | | +20.18% | 38.14B | | +2.62% | 30.09B | | -7.27% | 27.79B | | -20.22% | 25.5B |
Other Life & Health Insurance
|